takeaways from transatac trial on comparing prognostic signatures
Published 7 years ago • 119 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
1:50
challenges with patient selection for extended adjuvant endocrine therapy in breast cancer
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer
-
7:02
breast cancer recurrence risk based on ctdna
-
1:15
treating breast cancer in premenopausal women
-
0:55
canassist breast assesses the risk of breast cancer recurrence
-
13:38
breast cancer recurrence prevention - an illustrative tutorial from oster oncology
-
14:02
approval of capivasertib for pik3ca/akt1/pten–altered breast cancer: jason mouabbi and carlos doti
-
21:36
treatment planning for triple negative breast cancer | 2022 evolution conference
-
0:27
new accelerated partial breast irradiation guidelines
-
2:14
dr. formenti on concurrent adjuvant systemic therapy and accelerated radiotherapy in tnbc
-
4:11
targeted sequencing in endocrine refractory breast cancer
-
2:05
treatment advances in tnbc
-
2:38
insights from the uptider program in metastatic breast cancer
-
3:01
adjuvant endocrine therapy and risk of contralateral breast cancer
-
1:42
fast forward phase iii: hypofractionated whole breast irradiation
-
1:02
importance of sequencing immunotherapy in breast cancer
-
1:13
dr. tripathy on connecting markers to clinical outcomes
-
2:47
current treatment landscape of triple negative breast cancer
-
3:10
ascent trial: sacituzumab govitecan for tnbc
-
0:56
oncotarget | pre-treatment ultrasound used to predict breast cancer recurrence
-
1:32
sequencing treatment options in breast cancer
-
5:55
utilizing pathologic complete response in breast cancer trials